The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
"BY-HEALTH is actively expanding the development space of multiple categories through the combination product strategy of large single products, image products and star products."
https://www-prnasia-com.translate.goog/story/380377-1.shtml?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
After all the cash and effort By-Health have put into Fruitflow so far I have no doubt that any product launch will not be "small launch word of mouth"
As a thought.........
Where would Provexis be now if DSM had put in the same effort as B-H?
Ever , unlikely , Lifespace ‘s sales are exploding , and I would expect ff to do the same , “During the reporting period, the probiotics track performed well: "Life-Space" domestic products achieved revenue of 253 million yuan, a year-on-year increase of 53.33%; overseas business LSG operating income was 124 million Australian dollars, a year-on-year increase of 21.71%, continuing to maintain a growth trend”. That’s about £30m sales in China and £70m for the rest of the territories . £100m in just a couple of years .
it is easy to forget what a big deal getting BlueCap would be.
It is easy to forget TBH , we all expected PXS to take off post EU functional food rating status , nothing happened as no one was prepared to put in a massive amount of effort and cash to float a on every shelf product. Been over this many times. Fingers crossed the Chinese do this but don't hold your breath as they may just go with small launch word of mouth slow growth .
PR Newswire
"BY-HEALTH's revenue in the first three quarters was 6.16 billion yuan, with outstanding performance in scientific research"
During the reporting period, the company's scientific research achievements were dazzling, and authoritative articles were published in the fields of independent probiotic strain development and new mechanism research of qingluoxin (fruitflow), which attracted the attention of the industry.
In September, the latest research results of Qingluosu (fruitflow) jointly released by Tomson By-Health Nutrition and Health Research Institute and Institute of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences were published in the authoritative scientific journal "Frontiers in Nutrition". The mechanism indicates that BY-HEALTH has reached a new level in the innovative research and development of new functions.
https://www-prnasia-com.translate.goog/story/380377-1.shtml?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
By-Health website
http://www.by-health.com/news-4601
gixer ,Thank you for clearing this for me
Moon has nothing to do with provexis and hasn't for years.
Not seen anything negative reported and I don't expect any news on Thursday either.
Why indicate doom and gloom when there isn't any?
Would any body be able to tell if Mr Moon has anything to do with provexis anymore ,the reason i ak is .what is going on with sis ,this gives me the chills as provexis has been quite negative recently we need some positive news on Thursday, otherwise things are not looking good for us.
Thx Gixer
it is easy to forget what a big deal getting BlueCap would be.
I appreciate the snippets that those who make the effort to attend to AGM kindly share with us. It's not a cheap day out these days, could probably buy a few million shares at current SP for the cost of it!!
W$
Couple of articles relating to China's health food market/Industry
https://www-ifooday-cn.translate.goog/13-121572-1.html?_x_tr_sch=http&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
https://www-ifooday-cn.translate.goog/13-121561-1.html?_x_tr_sch=http&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
I totally agree with you ,we need more clarity on Bh
If anyone is going to the AGM, it would be good to get a better understanding of the SAMR process, the current position of BH in that process and the expected timeline for a ruling one way or another. They won’t give away any sensitive details regarding BH, but may give some broad timelines from a PXS standpoint.
"as the share price is 2 year low"
Not quite https://postimg.cc/7GPSZyps
Disappointing but not surprising that the share price has taken a dip with the further equity finance or potential loan finance that may be required to buy the remaining stock from DSM.
Look at the bigger picture, the market is a mess right now. A bad winter could make things look far worse IMHO
Of course, the high cost of energy is causing a world situation that will dampen consumer spending for years. Our political woes double down on the pain.
Is there no opinion out there ,regarding the up coming Agm on Thursday as the share price is 2 year low
closed below the 200 dMA , hasn't done that since April 20 . Doesn't seem like anything much is happening TBH.
Oh dear a new 2 year low
https://www.tradingview.com/x/bmCJ22Wp/
Dr Sarah Brewer gives FF a mention.
https://50connect.co.uk/health/poor-circulation/
Just had a little top-up at .6485 to reduce my average. This is the lowest sp level for almost 2 years and, as nothing appears to have changed I thought it worth a dabble.
If the read 50 MA crosses the Orange 200 MA we have a death cross
https://www.tradingview.com/x/JcV8Fnxw/
I think the controlled buying range will come to an end if sommatdontappen before Feb.
So Frederic is leaving DSM 3 months b4 the new PXS world order - could be a coincidence but a 3 months is probably his notice period. He shall be privvy to everything (multiple sales, funnels, etc blah blah) and I'm sure a small company like us could tempt him with lucrative stock options (big corps don't offer potential for jackpots - the DSM shares are heading south fast so his LTIPS might be worth jack atm) that might have value if what IF has been dangling in front of us is not just BS. Alternatively, what about BH, presumably he has been working closely with them ?
As good a conspiracy theory as any atm.....
W$
BB, FWIW I thought it was unlikely as well but it didn't stop me wondering.
:)
Gixer
Tis semantics, but I didn't say you did, I was just pointing out the, surely various reasons, that it's pretty darned unlikely !
Come 2023, DSM will primarly be a customer. In the short to medium term ( two or three years maybe ? ) , that'll be good for us, in that it gives us a real chance of moving into profitability.
But, if they thought FF sales were going to accelerate massively over that timescale, they'd have fought hard to keep the AA going so they had a decent slice of the pie. Maybe they did fight hard, but IF was driving a real hard bargain, maybe not ?
But, either way, none of that ties in with them having a place on the board as a NED.
Obviously now I've typed all that we'll get an RNS next week to prove I'm wrong which says someone from DSM is joining the board !
BB
Great stuff glad to hear it .
We didn't pay him or the previous DSM NED.
Why would we want the position filled ? another fat cat salary for doing nothing ! really , we are not a charity but it feels like it with IF taking over £100 k a year + share options , for what ?
PXS is in Zombie mode , we have the IP does anyone want it ? if so give us a offer please. IF BH are going to get stuck in with a big launch they will not want PXS holders benefitting way into the future imo.